v3.25.3
SCHEDULE OF PERFORMANCE SHARE UNITS GRANTED (Details) - USD ($)
 3 Months Ended
Sep. 24, 2025
Aug. 01, 2025
Oct. 31, 2025
Director [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted shares 100,000    
Grant date fair value $ 940,000    
Performance Shares [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of outstanding, beginning balance  
Aggregate intrinsic value, beginning balance  
Number of PSU's outstanding, granted   165,935 165,935 [1]
Aggregate intrinsic value, granted [1]     $ 1,434,513
Number of outstanding, ending balance     165,935
Aggregate intrinsic value, ending balance     $ 1,825,285
Grant date fair value   $ 353,228  
Officer [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Grant date fair value   70,643  
Chief Financial Officer [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Grant date fair value   $ 70,643  
[1] On August 1, 2025, the Company granted 165,935 performance-based stock units (“PSUs”) to the Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), Chief Medical Officer (“CMO”), and Chief Scientific Officer (“CSO”) under the Omnibus Plan. These PSUs contain performance conditions tied to the advancement of the Company’s Bria-IMT Phase 3 program, the Bria-OTS program, and certain corporate and governance objectives. The grant-date fair value of the PSUs awarded to these officers totaled $353,228. The PSUs awarded to the CMO and CSO include milestones related to the Bria-OTS program, with grant-date fair values of $70,643 each. The CFO’s PSUs relate to corporate and financial reporting objectives, with a grant-date fair value of $70,643.